isopentenyladenosine has been researched along with Inflammation in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bifulco, M; Capunzo, M; Ciaglia, E; Nicolin, V; Nori, SL; Pescatore, A; Prota, L; Santoro, A; Ursini, MV | 1 |
1 other study(ies) available for isopentenyladenosine and Inflammation
Article | Year |
---|---|
The isoprenoid end product N6-isopentenyladenosine reduces inflammatory response through the inhibition of the NFκB and STAT3 pathways in cystic fibrosis cells.
Topics: Anti-Inflammatory Agents; Cell Line; Cell Survival; Chemokine CCL5; Cystic Fibrosis; Glutathione Peroxidase; HEK293 Cells; Humans; Inflammation; Interleukin-8; Isopentenyladenosine; NF-kappa B; Signal Transduction; STAT3 Transcription Factor; Thioredoxin-Disulfide Reductase; Tumor Necrosis Factor-alpha | 2018 |